Blutex

Medicinal product

(Invented) name

Blutex

Active substance (s)

Atenololis

Strength

50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C07AB03, Atenolol

Marketing authorisation holder

Rivopharm Ltd., Airija

Date of authorisation

2002-08-28

Date of renewal

2012-11-29

Documents

3136_1_2 Pakuotės lapelis 180918.docx

3136_1_2 Blutex_tab RPP 180918.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Atenololis	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
5275	3747	1003747	lizdinė plokštelė	N30		Receptinis	LT/1/02/3136/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-03-31	Išregistruotas
2012-11-29	Perregistruotas
2002-08-28	Registruotas